Published On: May 3rd, 2021Categories:

Smith & Nephew PLC (Baa2 Stable/BBB- Stable) is a portfolio medical technology business that has been trading for over 160 years. Due to the pandemic, the company has underperformed the broader medical device subsector. Based on the fundamentals of the company and new product launches, we think that the USD denominated SNLN 2.032% maturing in 2030 (US83192PAA66) is offering an attractive opportunity to invest in the healthcare sector.

Don’t miss our latest publication! Discover us on www.bridport.ch

CONTACT US

Share this article :

Back to the news